XML 53 R9.htm IDEA: XBRL DOCUMENT
v3.22.1

VITAL INTELLIGENCE ACQUISITION | 12 Months Ended
--- | ---
Dec. 31, 2021
Vital Intelligence Acquisition |
VITAL INTELLIGENCE ACQUISITION | 4. VITAL INTELLIGENCE ACQUISITION On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”), a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it to diversify its existing product line as well as recognized opportunities that an initial focus on COVID-19 screening set of technologies would most likely lead to other facets within the healthcare field creating revenue growth from a new vertical, for consideration of: (a) a cash payment of $500,000 and (b) ‎1,200,000 units of the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $13.35 and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets. The units were issued on March 22, 2021. On August 19, 2021 the parties agreed to reduce the final payment from $250,000 to $227,984 due to certain assets listed in the purchase agreement had not been delivered by Vital. The units of the Company are to be releasable from escrow in accordance with the terms and conditions of the agreement, as follows:
| a) | 300,000 units shall be released on the closing date;
| b) | 300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
| c) | 300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
| d) | 300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.
Upon acquisition, the 900,000 shares held in escrow were classified as a derivative liability and were valued based upon:
| ● | A weighted average probability of achieving the milestones necessary to release the shares held in escrow, and
| ● | Discounted due to the lack of liquidity.
On acquisition, the fair value of the derivative liability (note 20) was $4,797,717. At December 31, 2021, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $694,230, with the difference flowing through the consolidated statement of loss. SCHEDULE OF CONTINGENT CONSIDERATION
Contingent consideration |  |  |  |
Fair value of contingent consideration |  | $ | 4,797,717 |
Change in fair value of contingent consideration |  |  | (4,103,487 | )
Contingent consideration at December 31, 2021 (note 20) |  | $ | 694,230 |
The PPA is as follows: SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE
Number of units of Draganfly Inc. |  |  | 578,248 |
Fair value of units |  | $ | 14.43 |
Fair value of units of Draganfly Inc. |  | $ | 8,342,966 |
Cash portion of purchase price |  |  | 466,643 |
Total |  | $ | 8,809,609 |
Identifiable intangible assets |  |  |
Brand |  | $ | 23,000 |
Software |  |  | 433,000 |
|  |  | 456,000 |
Goodwill |  |  | 8,353,609 |
Total consideration |  | $ | 8,809,609 |
Draganfly Inc. Notes to the Consolidated Financial Statements For The Year Ended December 31, 2021 Expressed in Canadian Dollars
4. | VITAL INTELLIGENCE ACQUISITION (CONT’D)
Significant estimates are as follows:
| ● | Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets.
| ● | Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% and discount rate of 14.4% per annum.
| ● | Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 14.4% per annum.
Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of continued development of the technology platform integrating the latest technological developments. From the date of the acquisition to December 31, 2021, Vital contributed $115,369 of revenue and a net loss of $203,231.

X
- Definition Disclosure of Vital Intelligence Acquisition [Text Block] + References No definition available. + Details
Name: | DPRO_DisclosureOfVitalIntelligenceAcquisitionTextBlock
Namespace Prefix: | DPRO_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | DPRO_DisclosureVitalIntelligenceAcquisitionAbstract
Namespace Prefix: | DPRO_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration